LIN vs STE · P/E 34, rev $33.99B vs P/E 25, rev $5.46B
Linde plc Ordinary Shares (LIN) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the LIN and STE stock pages for the full models.
Not investment advice.